Sanofi Teams Up With BST Japan To Develop GLP-1 Receptor Agonist Patch
This article was originally published in PharmAsia News
Executive Summary
Sanofi has announced a partnership with BioSerenTach, based in Kyoto city, regarding the development of a patch-type formulation of the GLP1 receptor agonist Lyxumia on June 26.